Bloom Named RML Associate Director
Dr. Marshall Bloom, an internationally recognized authority on Aleutian mink disease, persistent infections and parvoviruses, has been named associate director of Rocky Mountain Laboratories (part of NIAID) in Hamilton, Mont. He has a long history of service to the Hamilton campus and has been involved with numerous community outreach programs at RML. He chairs the RML community liaison group, composed of civic and community leaders, which was recently established to maintain an open dialogue as the laboratories plan for the growth of their research programs. This includes the building of a facility for conducting research that will lead to a better understanding of emerging infectious diseases and agents of bioterrorism and the development of diagnostics, therapies and vaccines to protect citizens from those agents. He is a long-time participant in the NIAID Introduction to Biomedical Research Program. He also coordinates the RML Summer Internship Program and has mentored and trained many doctoral fellows and students. The author of numerous scientific articles and book chapters, Bloom sits on the editorial board of Virology and is a member of the American Society of Microbiology, the American Association for the Advancement of Sciences and the American Society for Virology. He came to RML in 1972 as a research associate. In 1975, he was assigned to what was then the Laboratory of Biology of Viruses at NIAID in Bethesda, but he returned to RML as a tenured investigator in 1977. He is a charter principal investigator in the Laboratory of Persistent Viral Diseases at RML.
Wachtel Joins CSR
Dr. Marian Wachtel has joined the Center for Scientific Review as the new scientific review administrator of the special reviews study section that examines small business innovative research grant applications for the infectious diseases and microbiology integrated review group. She earned her Ph.D. in microbiology and molecular genetics at UCLA, studying attachment mechanisms of the human bacterial pathogen, Yersinia enterocolitica, in the gastrointestinal tract. At the Uniformed Services University of the Health Sciences, Wachtel helped characterize the intimin outer membrane protein of E. coli O157:H7 bacteria and received patents for developing an edible anti-intimin vaccine for cattle. Before joining CSR, she studied the attachment of E. coli O157:H7 to fruits and vegetables at the Department of Agriculture.
Kitt To Direct Extramural NIAMS
Dr. Cheryl A. Kitt recently joined NIAMS as director of its extramural program. She formerly served at NINDS as scientific and administrative team leader for the systems and cognitive neuroscience cluster and as program director for research in pain, neuroendocrinology, neurotoxicology, sleep and circadian rhythms and women's health research. Since coming to NIH in 1995, Kitt has worked on advisory committees for chronic fatigue syndrome, pain and research on women's health. She is a founding member of the NIH Pain Consortium. In March 2003, she will receive the John and Emma Bonica Public Service Award from the American Pain Society at its annual meeting in Chicago. The award recognizes contributions to the field of pain through information dissemination, education or public service.
Up to Top